Additionally, loss of miR-200a in meningiomas was shown to promote tumor growth by directly targeting beta-catenin (CTNNB1), but its role in BE remains unclear due to conflicting reports on the dysregulation of miR-200a [20, 31, 90]. This evidence concerns the gene CTNNB1 and neoplasm.